8-K
Current Report
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-22-035693
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading ea161465-8k_actinium.htm…